Letter: effectiveness of split‐dose certolizumab pegol for Crohn's disease

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2036|38|11-12|1412-1412

ISSN: 0269-2813

Source: ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.38, Iss.11-12, 2013-12, pp. : 1412-1412

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract